31 August 2017

Last week the NVAO (Accreditation Organisation of the Netherlands and Flanders) formally re-accredited the Molecular Mechanisms of Disease (MMD) research master program, which is part of the RIMLS graduate school.

Overall the programme received the distinctive grade of ‘Good’, with even an ‘Excellent’ for the learning objectives. In particular the evaluation committee was impressed by the translational approach of the programme that links fundamental research with clinical application. The form in which this is implemented was considered an international role model for comparable programmes.

As a consequence, by offering the best possible facilities and education to highly talented students to become independent researchers, the MMD programme makes an important contribution to the mission of the Radboudumc to have a significant impact on healthcare.

Related news items


Joint research in regional hospitals New research projects from promotion fund

22 November 2022

Four research projects have been honored in the promotion fund of the Radboudumc and four regional hospitals. The research projects, which are a collaboration between CWZ, Jeroen Bosch Hospital, Rijnstate, Sint Maartenskliniek and the Radboudumc will receive a contribution of 240,000 euros.

read more

Trained immunity’s role in kidney disease

17 November 2022

Researcher(s) Jordi Ochando of the Icahn School of Medicine at Mount Sinai in New York and Raphaël Duivenvoorden of the Department of Nephrology at Radboudumc explain how trained immunity can have detrimental effects in kidney disease and transplantation. 

read more